Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives Average Recommendation of “Hold” from Analysts

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) have earned an average recommendation of “Hold” from the six research firms that are covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $36.00.

SNN has been the subject of several research analyst reports. Canaccord Genuity Group lifted their price target on shares of Smith & Nephew SNATS from $28.00 to $36.00 and gave the company a “hold” rating in a research note on Monday, August 18th. Wall Street Zen upgraded Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 30th.

Hedge Funds Weigh In On Smith & Nephew SNATS

A number of large investors have recently modified their holdings of SNN. Hexagon Capital Partners LLC increased its stake in Smith & Nephew SNATS by 63.3% during the 1st quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 406 shares in the last quarter. Ashton Thomas Securities LLC grew its holdings in shares of Smith & Nephew SNATS by 0.9% during the second quarter. Ashton Thomas Securities LLC now owns 55,911 shares of the medical equipment provider’s stock valued at $1,713,000 after buying an additional 509 shares during the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of Smith & Nephew SNATS by 15.0% during the first quarter. Geneos Wealth Management Inc. now owns 4,149 shares of the medical equipment provider’s stock valued at $118,000 after buying an additional 541 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Smith & Nephew SNATS by 4.8% during the second quarter. Allspring Global Investments Holdings LLC now owns 12,462 shares of the medical equipment provider’s stock worth $381,000 after acquiring an additional 570 shares in the last quarter. Finally, Park Avenue Securities LLC raised its holdings in shares of Smith & Nephew SNATS by 6.3% in the 2nd quarter. Park Avenue Securities LLC now owns 9,789 shares of the medical equipment provider’s stock worth $300,000 after acquiring an additional 583 shares during the last quarter. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew SNATS Stock Performance

NYSE:SNN opened at $37.10 on Friday. The company has a quick ratio of 1.40, a current ratio of 3.00 and a debt-to-equity ratio of 0.60. Smith & Nephew SNATS has a twelve month low of $23.69 and a twelve month high of $38.79. The company has a fifty day moving average of $34.92 and a 200-day moving average of $30.68. The firm has a market capitalization of $16.16 billion, a P/E ratio of 17.18, a P/E/G ratio of 1.03 and a beta of 0.71.

Smith & Nephew SNATS Cuts Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 3rd will be issued a dividend of $0.285 per share. The ex-dividend date is Friday, October 3rd. This represents a dividend yield of 210.0%. Smith & Nephew SNATS’s payout ratio is currently 41.20%.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.